PET/CT in the Management of Thyroid Cancers
| Autor: | Rathan M. Subramaniam, Pat W. Whitworth, Devaki Shilpa Sudha Surasi, Charles Marcus, Sara I. Pai |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male endocrine system medicine.medical_specialty Pathology endocrine system diseases Medullary cavity Context (language use) Multimodal Imaging Sensitivity and Specificity medicine Humans Radiology Nuclear Medicine and imaging Thyroid Neoplasms Thyroid cancer Aged PET-CT business.industry Fdg uptake Thyroid Reproducibility of Results General Medicine Middle Aged Prognosis medicine.disease Endocrine cancer Treatment Outcome Somatostatin medicine.anatomical_structure Positron-Emission Tomography Female Radiology Tomography X-Ray Computed business |
| Zdroj: | American Journal of Roentgenology. 202:1316-1329 |
| ISSN: | 1546-3141 0361-803X |
| DOI: | 10.2214/ajr.13.11673 |
| Popis: | OBJECTIVE. Thyroid cancer is the most common endocrine cancer. This review evaluates the established use of 18F-FDG PET/CT in papillary, follicular, Hurthle cell, anaplastic, and medullary thyroid cancers. The significance of incidental diffuse and focal thyroid FDG uptake is discussed. The evolving value of non-FDG radiotracers, including 124I, 18F-dihydroxyphenylalanine, and 68Ga somatostatin analogs, is summarized. CONCLUSION. PET/CT is a valuable imaging test, in the appropriate clinical context, for the management of thyroid cancers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|